Vergis, Marissa .
HRN: 29-06-86 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/29/2026
05/30/2026
IV
300 Mg
Every 8 Hrs For 3 Doses
PROM
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines